Daniel Ehrsam studied Pharmaceutical Sciences and graduated at University of Basel in March 2014. He conducted his master thesis in research of brain ischemia pathways at Texas Tech Health Science Center under supervision of Dr. Margaret Weiss. He then worked at the Swiss Tropical and Public Health Institute on Helminth drug development (Prof. Dr. Jennifer Keiser). In August 2015 he joined the research group of Prof. Dr. Henriette E. Meyer zu Schwabedissen for his PhD studies. His research is focused on the development of an enzyme based targeted drug delivery system.